Compare · PGNY vs QIPT
PGNY vs QIPT
Side-by-side comparison of Progyny Inc. (PGNY) and Quipt Home Medical Corp. (QIPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PGNY and QIPT operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PGNY is the larger of the two at $1.42B, about 8.5x QIPT ($166.8M).
- Over the past year, PGNY is down 20.1% and QIPT is up 71.1% - QIPT leads by 91.2 points.
- PGNY has hit the wire 5 times in the past 4 weeks while QIPT has been quiet.
- PGNY has more recent analyst coverage (25 ratings vs 6 for QIPT).
- Company
- Progyny Inc.
- Quipt Home Medical Corp.
- Price
- $18.18+2.89%
- $3.65+0.00%
- Market cap
- $1.42B
- $166.8M
- 1M return
- +2.42%
- +2.24%
- 1Y return
- -20.05%
- +71.13%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 6
Progyny Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Quipt Home Medical Corp.
Quipt Home Medical Corp. provides in-home monitoring equipment and disease management services includes end-to-end respiratory solutions for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Latest PGNY
- Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
- SEC Form 4 filed by Cummings Melissa B
- Progyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental Plan
- SEC Form DEFA14A filed by Progyny Inc.
- SEC Form DEF 14A filed by Progyny Inc.
- Progyny Commemorates 10 Years of Redefining Women's Health and Family Building Care
- SEC Form PRE 14A filed by Progyny Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Progyny Inc.
- SEC Form 4 filed by Clapp Geoffrey
- Progyny Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest QIPT
- SEC Form 15-12G filed by Quipt Home Medical Corp.
- Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.
- Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Greenberg Mark Alan returned $1,589,418 worth of shares to the company (435,457 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Gamble Patrick Dennis returned $219,208 worth of shares to the company (60,057 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- President/CEO Crawford Gregory John returned $16,755,427 worth of shares to the company (4,590,528 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Carter Kevin A. returned $734,234 worth of shares to the company (201,160 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Bachelder David returned $80,869 worth of shares to the company (22,156 units at $3.65), closing all direct ownership in the company (SEC Form 4)